PMID- 25981172 OWN - NLM STAT- MEDLINE DCOM- 20170504 LR - 20220316 IS - 1873-2402 (Electronic) IS - 0006-3223 (Linking) VI - 79 IP - 10 DP - 2016 May 15 TI - Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels. PG - 858-868 LID - S0006-3223(15)00314-5 [pii] LID - 10.1016/j.biopsych.2015.03.033 [doi] AB - BACKGROUND: Disruption of the endocannabinoid system through pharmacological or genetic invalidation of cannabinoid CB1 receptors has been linked to depression in humans and depression-like behaviors in mice. The two main endogenous cannabinoids, anandamide and 2-arachidonoyl glycerol (2-AG), are produced on demand from phospholipids. The pathways and enzymes involved in endocannabinoid biosynthesis thus play a major role in regulating the activity of this system. This study investigates the role of the main 2-AG producing enzyme diacylglycerol lipase alpha (DAGL-alpha). METHODS: We generated and used knockout mice lacking DAGL-alpha (Dagla(-/-)) to assess the behavioral consequences of reduced endocannabinoid levels in the brain. We performed different behavior tests to determine anxiety- and depression-related behavioral changes in Dagla(-/-) mice. We also analyzed expression of genes related to the endocannabinoid system via real-time polymerase chain reaction and used the mitotic marker 5-bromo-2'-deoxyuridine to analyze adult neurogenesis. RESULTS: Dagla(-/-) animals show an 80% reduction of brain 2-AG levels but also a reduction in cortical and amygdalar anandamide. The behavioral changes induced by Dagla deletion include a reduced exploration of the central area of the open field, a maternal neglect behavior, a fear extinction deficit, increased behavioral despair, increased anxiety-related behaviors in the light/dark box, and reduced hippocampal neurogenesis. Some of these behavioral changes resemble those observed in animals lacking the CB1 receptor. CONCLUSIONS: Our findings demonstrate that the deletion of Dagla adversely affects the emotional state of animals and results in enhanced anxiety, stress, and fear responses. CI - Copyright (c) 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. FAU - Jenniches, Imke AU - Jenniches I AD - Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Ternes, Svenja AU - Ternes S AD - Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Albayram, Onder AU - Albayram O AD - Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Otte, David M AU - Otte DM AD - Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Bach, Karsten AU - Bach K AD - Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Bindila, Laura AU - Bindila L AD - Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Michel, Kerstin AU - Michel K AD - Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Lutz, Beat AU - Lutz B AD - Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Bilkei-Gorzo, Andras AU - Bilkei-Gorzo A AD - Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. FAU - Zimmer, Andreas AU - Zimmer A AD - Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.. Electronic address: a.zimmer@uni-bonn.de. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150414 PL - United States TA - Biol Psychiatry JT - Biological psychiatry JID - 0213264 RN - 0 (Endocannabinoids) RN - EC 3.1.1.34 (Lipoprotein Lipase) SB - IM CIN - Biol Psychiatry. 2016 May 15;79(10 ):e78-e79. PMID: 26212898 CIN - Biol Psychiatry. 2016 May 15;79(10 ):e80-e81. PMID: 26410564 CIN - Biol Psychiatry. 2016 May 15;79(10 ):792-793. PMID: 27130852 MH - Animals MH - Anxiety/*metabolism MH - Brain/metabolism MH - Cohort Studies MH - Endocannabinoids/*metabolism MH - Exploratory Behavior/physiology MH - Extinction, Psychological/physiology MH - Fear/*physiology MH - Female MH - Lipoprotein Lipase/*deficiency/genetics MH - Male MH - Maternal Behavior/physiology MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Motor Activity/physiology MH - Neurogenesis/physiology MH - Social Behavior MH - Stress, Psychological/*metabolism OTO - NOTNLM OT - Anxiety OT - Cannabinoids OT - Dagla OT - Depression OT - Fear extinction OT - Stress EDAT- 2015/05/20 06:00 MHDA- 2017/05/05 06:00 CRDT- 2015/05/19 06:00 PHST- 2014/10/23 00:00 [received] PHST- 2015/03/20 00:00 [revised] PHST- 2015/03/27 00:00 [accepted] PHST- 2015/05/19 06:00 [entrez] PHST- 2015/05/20 06:00 [pubmed] PHST- 2017/05/05 06:00 [medline] AID - S0006-3223(15)00314-5 [pii] AID - 10.1016/j.biopsych.2015.03.033 [doi] PST - ppublish SO - Biol Psychiatry. 2016 May 15;79(10):858-868. doi: 10.1016/j.biopsych.2015.03.033. Epub 2015 Apr 14.